106 related articles for article (PubMed ID: 12187003)
1. The effect of combined therapy with immunoadsorption and high-dose intravenous methylprednisolone on myasthenia gravis.
Munakata R; Utsugisawa K; Nagane Y; Yamagata M; Oikawa M; Obara D; Tohgi H
Eur Neurol; 2002; 48(2):115-7. PubMed ID: 12187003
[No Abstract] [Full Text] [Related]
2. [Myasthenia gravis: life-saving effect of a massive dose of intravenous methylprednisolone].
Szobor A; Bárdosi Z; Klátyik M; Klein M
Orv Hetil; 1988 Mar; 129(10):495-6, 499. PubMed ID: 3362539
[No Abstract] [Full Text] [Related]
3. Early aggressive treatment strategy against myasthenia gravis.
Nagane Y; Suzuki S; Suzuki N; Utsugisawa K
Eur Neurol; 2011; 65(1):16-22. PubMed ID: 21116111
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of immunoadsorption therapy in the treatment of myasthenia gravis and the mechanism].
LI QL; XIE FH; LUO YS
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Mar; 31(3):561-3. PubMed ID: 21421508
[TBL] [Abstract][Full Text] [Related]
5. Treatment of myasthenia gravis with methylprednisolone pulse: a double blind study.
Lindberg C; Andersen O; Lefvert AK
Acta Neurol Scand; 1998 Jun; 97(6):370-3. PubMed ID: 9669469
[TBL] [Abstract][Full Text] [Related]
6. Immunoadsorption With a Tryptophan-Immobilized Column Using Conventional and Selective Plasma Separators in the Treatment of Myasthenia Gravis.
Ohkubo A; Kurashima N; Okado T
Ther Apher Dial; 2018 Jun; 22(3):301-302. PubMed ID: 29781125
[No Abstract] [Full Text] [Related]
7. Efficacy of high-dose intravenous methylprednisolone therapy for ocular myasthenia gravis.
Ozawa Y; Uzawa A; Kanai T; Oda F; Yasuda M; Kawaguchi N; Himuro K; Kuwabara S
J Neurol Sci; 2019 Jul; 402():12-15. PubMed ID: 31100651
[TBL] [Abstract][Full Text] [Related]
8. [The effect of plasmapheresis with high-dose intravenous methylprednisolone therapy on cytokine synthesis of peripheral blood monocyte from patients with myasthenia gravis].
Matsubara R; Utsugisawa K; Ngane Y
No To Shinkei; 1995 Jul; 47(7):681-6. PubMed ID: 7612386
[TBL] [Abstract][Full Text] [Related]
9. [Long-term treatment of refractory myasthenia gravis with immunoadsorption].
Wagner S; Janzen RW; Mohs C; Pohlmann S; Klingel R; Grützmacher PW
Dtsch Med Wochenschr; 2008 Nov; 133(46):2377-82. PubMed ID: 18988129
[TBL] [Abstract][Full Text] [Related]
10. [Plasmapheresis in patients with myasthenia gravis].
Konishi T
Nihon Rinsho; 2008 Jun; 66(6):1165-71. PubMed ID: 18540364
[TBL] [Abstract][Full Text] [Related]
11. Double filtration plasmapheresis benefits myasthenia gravis patients through an immunomodulatory action.
Zhang L; Liu J; Wang H; Zhao C; Lu J; Xue J; Gu Y; Hao C; Lin S; Lv C
J Clin Neurosci; 2014 Sep; 21(9):1570-4. PubMed ID: 24814857
[TBL] [Abstract][Full Text] [Related]
12. [Immunoadsorption--a new treatment of myasthenia gravis].
Berning T; Krummenerl T; Glaser J; Paulus H; van Husen N
Med Klin (Munich); 1988 Feb; 83(4):125-8. PubMed ID: 3285161
[No Abstract] [Full Text] [Related]
13. Therapeutic apheresis in myasthenia gravis patients: a six year follow-up.
Schneidewind JM; Zettl UK; Winkler RE; Ramlow W; Tiess M; Hofmann D; Michelsen A; Weber G; Kinze EM; Adam U; Hauk L; Behnecke R; Klinkmann H
Ther Apher; 1999 Nov; 3(4):298-302. PubMed ID: 10608721
[TBL] [Abstract][Full Text] [Related]
14. Initial deterioration and intravenous methylprednisolone therapy in patients with myasthenia gravis.
Sugimoto T; Ochi K; Ishikawa R; Tazuma T; Hayashi M; Mine N; Naito H; Nomura E; Kohriyama T; Yamawaki T
J Neurol Sci; 2020 May; 412():116740. PubMed ID: 32145521
[TBL] [Abstract][Full Text] [Related]
15. [Intermittent methylprednisolone pulse therapy for myasthenia gravis in childhood].
Tanaka J; Matsuzaki K; Arai H; Nagai T; Matsumoto Y; Okada S
No To Hattatsu; 1994 Jan; 26(1):14-9. PubMed ID: 8280441
[TBL] [Abstract][Full Text] [Related]
16. Comparing the autoantibody levels and clinical efficacy of double filtration plasmapheresis, immunoadsorption, and intravenous immunoglobulin for the treatment of late-onset myasthenia gravis.
Liu JF; Wang WX; Xue J; Zhao CB; You HZ; Lu JH; Gu Y
Ther Apher Dial; 2010 Apr; 14(2):153-60. PubMed ID: 20438536
[TBL] [Abstract][Full Text] [Related]
17. Treatment of myasthenia gravis with dropped head: a report of 2 cases and review of the literature.
Tamai M; Hashimoto T; Isobe T; Sato H; Doden T; Nakano T
Neuromuscul Disord; 2015 May; 25(5):429-31. PubMed ID: 25747003
[TBL] [Abstract][Full Text] [Related]
18. [Randomized controlled clinical trial of middle-dose cyclophosphamide plus methylprednisolone for myasthenia gravis patients in crisis].
Feng HY; Liu WB; Qiu L; Huang X; Luo CM; Li Y; Wang HY
Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(35):2473-6. PubMed ID: 23158712
[TBL] [Abstract][Full Text] [Related]
19. [Results of myasthenia treatment with methylprednisolone pulses. Preliminary study].
Owczarek E; Emeryk-Szajewska B; Strugalska-Cynowska M
Neurol Neurochir Pol; 1995; 29(5):651-61; quiz 662. PubMed ID: 8584092
[TBL] [Abstract][Full Text] [Related]
20. Treatment for refractory myasthenia gravis.
Sakano T; Hamasaki T; Kinoshita Y; Kihara M; Ueda K
Arch Dis Child; 1989 Aug; 64(8):1191-3. PubMed ID: 2782938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
